Try GOLD - Free
Our vision is to make pharma marketing effective and efficient
Express Pharma
|December 2020
Doceree, a physician-only platform for programmatic marketing, is working towards building more effective ways for pharma brands to keep the doctors community engaged. Dr Harshit Jain, Founder and CEO, Doceree, outlines why it is important for pharma brands to redraw their doctor engagement strategies with the help of digital tools to reduce marketing costs, improve outcomes and ensure regulatory compliance, in an interview with Usha Sharma
Give us a brief understanding of Doceree? What is its USP?
Doceree is the global physician-only platforms for programmatic marketing. Our platform is disrupting the physician marketing landscape much in the same way digital ad networks transformed the consumer marketing space. Doceree’s integrated and collaborative ecosystem enables pharmaceutical brands and digital platforms to mutually benefit from the untapped opportunities present in physician marketing in the most ‘regulatory compliant and transparent manner’.
Doceree is enabling Rx drug marketers to promote their brands in the digital domain to physicians in a regulated manner. At the same time, Doceree provides an opportunity for digital platforms to make more revenue. With our platform, they can now focus on their core business and the problems they are solving in healthcare than swaying their attention to making more monies. Effectiveness and efficiency are our prime differentiators that come from our razor-sharp focus on doctor-only platforms. Unlike other companies in the US where we have competition in programmatic physician marketing space, Doceree is focussing on doctor-only platforms for pharma brands to market themselves.
Besides this, we are the only company in the category that has a global footprint with offices in the US and India. In India, we are the only programmatic platform in physician marketing. The underlying thought is to ensure effectiveness. Our proprietary identity resolution tool - Espyian helps precision target physicians, bringing in efficiency to physician marketing.
This story is from the December 2020 edition of Express Pharma.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Express Pharma
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Translate
Change font size

